Cargando…
miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma
BACKGROUND: The asymptomatic onset, frequent recurrence, and poor prognosis of hepatocellular carcinoma (HCC) prompted us to identify new therapeutic targets or predictive markers of HCC diagnosis or prognosis. METHODS: In this study, bioinformatics analysis was used to screen for target miRNAs from...
Autores principales: | Chen, Kai, Li, Zhonghu, Zhang, Mengyun, Wang, Bo, Peng, Tao, Shen, Yanbing, Zhang, Jianxin, Ye, Jiaxin, Liu, Yu, Tang, Di, Peng, Minjie, Ma, Dandan, Xiao, Zhengkang, Zhang, Yujun, Jin, Weidong, Li, Xiaowu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559219/ https://www.ncbi.nlm.nih.gov/pubmed/33083453 http://dx.doi.org/10.1155/2020/1964219 |
Ejemplares similares
-
Erratum to “miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma”
por: Chen, Kai, et al.
Publicado: (2020) -
SLCO4A1-AS1 mediates pancreatic cancer development via miR-4673/KIF21B axis
por: Zhang, Jianxin, et al.
Publicado: (2022) -
Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2019) -
Correction to: Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2021) -
Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction
por: Jia, Li, et al.
Publicado: (2022)